肝硬化质量指标与全因死亡率及医疗使用:退伍军人全国队列研究
该回顾性研究纳入2008至2016年128家退伍军人机构的121,129例新诊断肝硬化患者,评估6项肝硬化质量指标的依从性及其与全因死亡率和医疗使用的关系。结果显示5项指标可测量,其中4项依从性与较低全因死亡率相关,再入院与较高死亡率相关,高依从性亦与较低住院医疗使用相关。
要点
- 门诊专科就诊依从率71%,静脉曲张监测32%,出院后早期照护54%。
- 门诊专科就诊(HR 0.80)、肝癌监测(HR 0.92)、静脉曲张监测(HR 0.93)、出院后早期照护(HR 0.57)与较低全因死亡率相关。
- 30天再入院(HR 1.53)和90天再入院(HR 1.88)与较高全因死亡率相关。
核心结论
- 6项拟议的退伍军人事务部肝硬化质量指标中有5项可使用现有数据源测量,与死亡率和医疗使用相关,并可能用于指导未来肝硬化质量改进工作。
研究设计与样本
- 回顾性研究,使用退伍军人肝病结局与费用队列中2008年1月1日至2016年12月31日在128家退伍军人事务部机构新诊断肝硬化的121,129例患者数据。
- 平均随访时间2.7年(四分位距1.1-5.1年)。
主要发现
- 门诊专科就诊依从率为71%,静脉曲张监测依从率为32%,出院后早期照护依从率为54%。
- 调整分析中,门诊专科就诊(HR 0.80;95%CI 0.78-0.82)、肝癌监测(HR 0.92;95%CI 0.90-0.95)、静脉曲张监测(HR 0.93;95%CI 0.89-0.99)和出院后早期照护(HR 0.57;95%CI 0.54-0.60)与较低全因死亡率相关。
- 30天再入院(HR 1.53;95%CI 1.46-1.60)和90天再入院(HR 1.88;95%CI 1.54-1.70)与较高全因死亡率相关。
- 对质量指标的较高依从性也与较低的住院医疗使用相关。
关键数值与推荐
- 退伍军人事务部晚期肝病技术咨询组制定了6项内部质量指标,涵盖专科就诊可及性、肝癌监测、静脉曲张监测、上消化道出血住院照护质量和肝硬化相关再入院。
- 6项质量指标中5项可使用现有数据源测量。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Decompensated cirrhosis is associated with high morbidity and mortality. However, no standardized quality measures (QMs) have yet been adopted widely. The Veterans Affairs (VA) Advanced Liver Disease Technical Advisory Group recently developed a set of six internal QMs to guide quality improvement efforts in cirrhosis in the domains of access to care, hepatocellular carcinoma surveillance, variceal surveillance, quality of inpatient care for upper gastrointestinal bleeding, and cirrhosis-related rehospitalizations. We aimed to (1) quantify adherence to cirrhosis QMs and (2) determine whether adherence was associated with all-cause mortality and health care use within a large national cohort of veterans with cirrhosis. We performed a retrospective study using data from the Veterans Outcomes and Costs Asociated with Liver Disease cohort of 121,129 patients newly diagnosed with cirrhosis from January 1, 2008, to December 31, 2016, at 128 VA facilities. The mean follow-up time was 2.7 years (interquartile range, 1.1-5.1 years). Adherence to outpatient access to specialty care was 71%, variceal surveillance was 32%, and early postdischarge care was 54%. In adjusted analyses, outpatient access to specialty care (hazard ratio [HR], 0.80; 95% confidence interval [CI], 0.78-0.82), hepatocellular carcinoma surveillance (HR, 0.92; 95% CI, 0.90-0.95), variceal surveillance (HR, 0.93; 95% CI, 0.89-0.99), and early postdischarge care (HR, 0.57; 95% CI, 0.54-0.60) were associated with lower all-cause mortality. Readmissions after 30 days (HR, 1.53; 1.46-1.60) and 90 days (HR, 1.88; 95% CI, 1.54-1.70) were associated with higher all-cause mortality. Higher adherence to QMs was also associated with lower inpatient health care use. Conclusion: Five of the six proposed VA cirrhosis QMs were measurable using existing data sources, associated with mortality and health care use, and may be used to guide future quality improvement efforts in cirrhosis.
引用
- Serper M, Kaplan DE, Shults J, et al. Quality Measures, All-Cause Mortality, and Health Care Use in a National Cohort of Veterans With Cirrhosis. Hepatology. 2019. PMID: 31107967. doi:10.1002/hep.30779
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。